期刊文献+

那格列奈片的制剂学研究 被引量:2

Preparation study on Nateglinide tablets
下载PDF
导出
摘要 目的:筛选那格列奈片的处方、优化工艺,并对本片进行质量研究。方法:处方及工艺研究采用比较法,含量测定、溶出度测定、有关物质检查采用HPLC法。结果:所选处方合理、工艺可行,HPLC方法灵敏、可靠、重复性好、操作简单,能够很好地控制本片的质量。结论:按照该处方及工艺压制的那格列奈片具有良好的稳定性,本研究为新药报批提供了制剂学研究资料。 Objective:To screen formulations,optimize preparing technics and study on quality control of Nateglinide tablets.Methods: The comparation method was used in formulation and technics study,and a HPLC method was applied in content determination,dissolution and related materials study.Results:A reasonable formulation and feasible technics were found,the HPLC method established were sensitive,reliable and simple with good reproductivity,and the quality of Nateglinide tablets were under control very well.Conclusion:Nateglinide tablets prepared with the optimized formulation and technics demonstrated good stability. This study offered preparation study data for the new drug registration.
出处 《中国药物应用与监测》 CAS 2005年第1期54-56,共3页 Chinese Journal of Drug Application and Monitoring
关键词 那格列奈片 糖尿病 药物制剂学 Nateglinide tablets:Diabetes:Preparation
  • 相关文献

参考文献3

  • 1[1]McCarty D,Zimmet P.Diabetes 1994 to 2010:global estimates and projections[M].Melbourne:International Diabetes Institute,1994.
  • 2[2]Scheen AJ.Drug treatment of NIDDM in the 1990s[J].Drugs,1997,54(3):355.
  • 3[3]Mooradian AD,Thurman JE.Drug therapy of postprandial hypergement of type 2 diabetes mellitus[J].Drugs, 1998,55(4):563.

同被引文献16

  • 1李纪鹏.那格列奈和二甲双胍联合用药治疗2型糖尿病疗效的比较[J].实用糖尿病杂志,2006,2(2):53-54. 被引量:5
  • 2方福生,李春霖.二甲双胍的临床应用及研究进展[J].中国药物应用与监测,2007,4(1):7-10. 被引量:8
  • 3Kikuehi M. Preclinical of AY4166(A-4166) [J]. Jpn J Clin Med, 1997,55(S1) : 159.
  • 4Ichiro ono, Keizo Matsuda, Sachiko Kanno. Determination of N-(Trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and its metabolites in human plasma and urine by column-switching HPLC with ultraviolet detection[J]. J Chromatogr B,1997,(692):397.
  • 5Shinkai H, Nishikawa M, Sato Y, et al. Separation of a new antidiabetic agent, N-(Trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine and its isomers by chiral HPLC[J]. J Lip Chromatogr, 1989,12(3) :457.
  • 6Deeks ED, Scott LJ. Pioglitazone/metformin[J]. Drugs, 2006, 66(4): 1863-1877.
  • 7Horton ES, Foley JE, Shen S.I, et al. Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naive patients with type 2 diabetes[J]. Curt Med Res Opin, 2004, 20(6): 883-889.
  • 8Marre M, Van Gaal L, Usadel KH, et al. Nateglinide improves glyeaemic control when added to metformin monotherapy: results of a randomized trial with type 2 diabetes patients[J]. Diabetes Obes Metab, 2002, 4(3): 177-186.
  • 9Horton ES, Clinkingbeard C, Gatlin M, et al. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes[J]. Diabetes Care, 2000, 23(11): 1660-1665.
  • 10徐文华,崔刚,丁元红.那格列奈联合二甲双胍治疗初发2型糖尿病的临床观察[J].海南医学院学报,2009,15(3):274-275. 被引量:6

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部